Back Login to subscribe 🔔 Set Alert

GMED GLOBUS MEDICAL INC

15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
GMED Fundamental Data
Loading...
Similar Companies
Loading...
GMED Options Chain
Put/Call Ratio
-
-
Expected Move
-
-
Max Pain
-
-
ATM Call Break-even
-
-
ATM Put Break-even
-
-
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
GMED Insider Transactions
Loading insider data…
GMED News
Date Headline Sentiment
Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99
70.34%
Global Medical shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjsuted EPS guidance above estimates.
95.64%
Globus Medical Raises FY2026 Adj EPS Guidance from $4.70-$4.80 to $4.95-$5.05 vs $4.74 Est; Affirms FY2026 Sales Guidance of $3.180B-$3.220B vs $3.201B Est
80.39%
Globus Medical Q2 Adj. EPS $1.34 Beats $1.10 Estimate, Sales $789.612M Beat $782.840M Estimate
94.81%
Shares of medical device-related companies are trading higher following comments from HCA Healthcare on a conference call that business declines from uninsured patients didn't occur as expected in Q2, which is bullish for the medical device and equipment outlook following the end of ACA subsidies.
75.79%
Shares of medical device companies are trading lower amid sympathy with Intuitive Surgical after the company reported Q2 financial results and noted that the China market remains a challenge. Also, multiple analysts lowered their respective price targets on ISRG.
96.67%
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100
55.41%
Shares of medical device-related companies are trading lower after HCA Healthcare noted a Q2 increase in uninsured patient volumes and a decline in surgical volume, which may dim the outlook for device pricing power and margins.
97.27%
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115
94.42%